Sanofi

Three years after In Vivo identified AI in biologics as “an emerging frontier,” pharmaceutical companies are doubling down with billion-dollar partnerships and comprehensive internal platforms. Ye

The consumer representative for the US Food and Drug Administration’s Pediatric Advisory Committee said the adverse event reporting system needs improvement and the agency’s postmarketing surveillance

Frontline Indian firms appear keen to accelerate product in-licensing deals with foreign companies and these efforts have now evolved from a “supplementary tactic” to a cornerstone of their strategy,

Apogee Therapeutics has posted positive data from its long-acting antibody, APG777, that showed it reduced symptoms of the inflammatory skin condition atopic dermatitis in a 123-patient Phase II study